Intensified Adjuvant Chemo No Better Than Standard in High-Risk Colon Cancer

Summary
(MedPage Today) -- Intensified adjuvant chemotherapy did not improve disease-free survival (DFS) compared with standard chemotherapy in patients with high-risk stage III colon cancer, the phase III IROCAS trial showed. The 3-year DFS rate was...
Description from Medpagetoday.
Who is covering this
-
Intensified Adjuvant Chemo No Better Than Standard in High-Risk Colon Cancer
(MedPage Today) -- Intensified adjuvant chemotherapy did not improve disease-free survival (DFS) compared with standard chemotherapy in patients with high-risk stage III colon cancer, the phase III IROCAS trial showed. The 3-year DFS rate was...